Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation TCT 2025

Cephea™ Mitral Valve System for Symptomatic Mitral Valve Disease: 1-Year Outcomes of the Early Feasibility Study

Presenter: Torsten P. Vahl

October 27, 2025

News Conference News TCT 2024

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

Todd Neale

October 31, 2024

Presentation TCT 2024

Variations in New Clinical Trial Designs for Emerging CEP Devices

Presenter: Alexandra Lansky

October 30, 2024

Presentation TCT 2024

Novel Technologies in CEP During TAVR: Emboliner, ProTembo, Emblok, Filterex, and Others

Presenter: Tamim Nazif

October 30, 2024

Presentation TCT 2024

Primary Endpoint Results with the Second-Generation Cephea Transseptal TMVR System in Complex Mitral Valve Disease

Presenter: Pradeep Yadav

October 29, 2024

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

Case: Evolving Stroke After TAVR

Presenter: Jason Bloom

October 28, 2024

Presentation TCT 2024

Incidence, Diagnosis, and Management of Evolving Strokes After TAVR

Presenter: Julia Seeger

October 28, 2024

Presentation TCT 2024

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

Presenter: Aakriti Gupta

October 28, 2024

Presentation TCT 2024

CEP Technology Landscape and Study Design

Presenter: Mathew Williams

October 28, 2024

Presentation TCT 2023

Point: PROTECTED TAVR – The Case for CEPD

Presenter: Axel Linke

October 26, 2023

Presentation TCT 2023

Cephea

Presenter: Pradeep Yadav

October 24, 2023

Presentation TCT 2023

Cephea

Presenter: Pradeep Yadav

October 24, 2023

Presentation TCT 2022

New and Novel CEP Devices: Differentiating Features

Presenter: Giora Weisz

September 17, 2022

Presentation TCT 2022

The Journey of CEP from Clean TAVI to PROTECTED TAVR: Lessons Learned

Presenter: Axel Linke

September 17, 2022

News Conference News TCT 2022

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope

Todd Neale

September 17, 2022

Presentation TCT 2019

Transseptal III: Cephea — Device Description, Results, and Ongoing Studies

Presenter: Thomas Modine

September 28, 2019

Presentation TCT 2017

Emerging TMVR 1: Cephea - Device Description, Critical Appraisal, and Development Plans

Presenter: Juan F. Granada

October 31, 2017

Presentation TCT 2016

Cephea: Design Development Update

Presenter: Juan F. Granada

October 31, 2016

Presentation TCT 2015

Cephea: Novel Design Features and Clinical Updates

Presenter: Juan F. Granada

October 12, 2015

Advertisement

Cephea™ Mitral Valve System for Symptomatic Mitral Valve Disease: 1-Year Outcomes of the Early Feasibility Study

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

Variations in New Clinical Trial Designs for Emerging CEP Devices

Novel Technologies in CEP During TAVR: Emboliner, ProTembo, Emblok, Filterex, and Others

Primary Endpoint Results with the Second-Generation Cephea Transseptal TMVR System in Complex Mitral Valve Disease

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

Case: Evolving Stroke After TAVR

Incidence, Diagnosis, and Management of Evolving Strokes After TAVR

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

CEP Technology Landscape and Study Design

Point: PROTECTED TAVR – The Case for CEPD

Cephea

Cephea

New and Novel CEP Devices: Differentiating Features

The Journey of CEP from Clean TAVI to PROTECTED TAVR: Lessons Learned

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope

Transseptal III: Cephea — Device Description, Results, and Ongoing Studies

Emerging TMVR 1: Cephea - Device Description, Critical Appraisal, and Development Plans

Cephea: Design Development Update

Cephea: Novel Design Features and Clinical Updates

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content